Tehuan Harris is a news and features journalist at Collider, reporting and writing about all things music and reality TV (sometimes). She is a talented journalist and a natural storyteller who writes ...
The gates of R. Kelly’s onetime “Chocolate Factory” mansion in suburban Chicago have closed for good — and at a steep discount. The 21,000-square-foot estate, where the R&B singer once recorded hits ...
Curious from birth, Fiona is a music writer, researcher, and cultural theorist based in the UK. She studied her Bachelor of Music in London, specializing in audiovisual practices, and progressed to a ...
Some of the greatest hits in music history came together in a flash of inspiration — proof that genius doesn’t always need time. Some songs take months of studio perfectionism to get right, while ...
For some truly unexplainable reason, these three iconic hit country songs never made it to No. 1 on the charts.
A song can only hit the top of the charts by knocking another song down, and that's precisely what these three 1971 hit songs did.
Ace Frehley’s biggest solo hit subsequently landed at Number 3 on a list of the Top 10 KISS songs on the Hot 100, per Billboard. "Back in the New York Groove" ranked third behind the 1976 tunes "Beth" ...
If there’s anything that defines music in the 21st century, it’s constant change. We live in an era when your next favorite song could come from anywhere — all over the stylistic map, all over the ...
"One, two, three, and to the four," Snoop Dogg says after a contestant on The Voice wins a chair-turn and from all of the coaches. The one-named performer from Connecticut sang En Vogue's "Don't Let ...
The 2000s feel like just yesterday, and for many, it was the beginning of the future where flying cars and space travel would be the norm. Well, at least of music going from physical formats like CDs ...
Tickets go on sale this Friday. "Dancing with the Stars" is hitting the road again. The "DWTS" pros -- along with some "celebrity guest stars" yet to be announced -- will tour again in 2026, according ...
AbbVie has warned investors that it expects to take a $2.7 billion hit tied to acquired in-process research and development (IPR&D) expenses and milestones in the third quarter. Like other drugmakers, ...